Business
Acacia Research is a holding company and acquisition platform with businesses across intellectual property licensing, manufacturing, energy, and industrial products.
Acacia turned profitable, expanded free cash flow, and drew a CFO purchase after a portfolio reshaping year.
The read at a glance✓ Audited against SEC data
- Business mix — IP, manufacturing, energy, and industrial holdingsNote
- Revenue — Revenue +133.2% to $285MOK
- Profitability — Net income swung to $21.7MOK
- Cash quality — Free cash flow improved to $61.1MOK
- Margins — Operating margin improved to 2.25%OK
- Insiders — 1 buy / 0 sells by CFOOK
- Accounting — Altman grey; EQ safeNote
Where the revenue comes from
Fiscal 2025, as ACACIA RESEARCH CORP reports it. History and quarterly detail are in the app.
- Manufacturing Operations$114.8M
- Intellectual property operations$78.4M
- Energy operations$63.8M
- Industrial operations$28.3M
Leadership changes
From ACACIA RESEARCH CORP's own filings, the day they're filed.
- Michael Zambito · Chief Financial Officer · appointmenteff. 2025-06-24
- Ajay Sundar · Director · appointmenteff. 2024-02-13
- Starboard Value · director · appointmenteff. 2024-02-13
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-06-25
- 8-K · Company announcement2026-05-07
- 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ACACIA RESEARCH CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.